Navigation Links
AstraZeneca Among Working Mother Magazine's 2009 'Best Companies'
Date:9/22/2009

WILMINGTON, Del., Sept. 22 /PRNewswire-FirstCall/ --- AstraZeneca (NYSE: AZN) has been recognized as one of the 2009 Working Mother 100 Best Companies for the eighth consecutive year. This award acknowledges the company's commitment to family-friendly policies that support employee retention, employee engagement, and career advancement.

This year, the company was recognized specifically for its best practices in parental leave and training and development. AstraZeneca provides each eligible employee with up to 52 weeks of combined paid and unpaid leave, 26 weeks of which is job guaranteed, to care for their newborn child, adopted or foster child. The company also offers paid adoption leave.

In training and development, the company expanded the IDEA program, which provides short term development opportunities to enable individuals to develop new skills and explore alternate careers through work experience in different areas within the company while staying in their current position. The program matches employees who want to learn and have skills to share with host project managers.

"AstraZeneca strives to create an inclusive culture of innovation and opportunity to help employees manage the growing demands of work and personal life," says Marta Brito Perez, Vice President, Human Resources, North America & Global Marketing. "This recognition from Working Mother magazine underscores our commitment to the health and welfare of our employees."

Additional programs the company offers include:

  • Childcare and eldercare resources, services and discounts
  • Flexible work arrangements
  • Work/life seminars
  • Employee Assistance Program providing confidential, personal support, resources and referrals
    '/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AstraZeneca Leads Local Walking Movement
2. AstraZeneca Joins Local Walking Movement
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
5. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
6. AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
7. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
8. Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca
9. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... “Dr. Luciana Show – Aging and Falling” is ... is finding it challenging to stay on top of post-production ... hundreds of students, so the editing of the episodes will ... and she recently entered it into the festival circuit. ... husband, actor/screenwriter Gregory Graham , the aging and falling ...
(Date:8/22/2014)... Oncology (ESMO), the leading pan-European organisation representing medical ... outstanding individuals receiving the Society,s esteemed annual awards. ... Heikki Joensuu and Peter Boyle on the occasion ... Spain. , Carsten Bokemeyer will receive the ESMO ... of cancer discovery into real benefit at patient ...
(Date:8/22/2014)... Chest pain, breathing difficulties, fainting. Each year approx. 265,000 ... of serious illness. New research from Aarhus University and ... as many as every fourth patient are ... severe symptoms that led to the acute hospitalisation., "Naturally, ... examinations at the hospital disprove that there is a ...
(Date:8/22/2014)... can be slowed and some of its symptoms ... in pomegranate. Also, the painful inflammation that ... disease could be reduced, according to the findings ... Huddersfield scientist Dr Olumayokun Olajide, who specialises in ... a new phase of research can explore the ...
(Date:8/22/2014)... treated for the cancer Hodgkin lymphoma will be able ... researchers estimated their risk of premature menopause with different ... Journal of the National Cancer Institute , are based ... in England and Wales treated for the cancer over ... research has suggested that women with Hodgkin lymphoma who ...
Breaking Medicine News(10 mins):Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Many patients are discharged without a diagnosis 2Health News:Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's 2Health News:Scientists map risk of premature menopause after cancer treatment 2
... Elsevier , the world-leading publisher of scientific, technical ... Silverstein whose new book, The Initial Psychotherapy ... Award from the American Psychological Association,s Society for ... Transgender Issues. Dr. Silverstein also received a Gold ...
... Reporter , WEDNESDAY, Aug. 24 (HealthDay News) -- The percentage ... 14 percent from 22 percent in 2008, a new survey ... the September issue of Obstetrics & Gynecology , don,t ... according to those on both sides of the abortion debate. ...
... Gordon HealthDay Reporter , WEDNESDAY, Aug. ... of the antibiotic azithromycin may help prevent life-threatening ... say. These complications are commonly referred to ... doctor visits and hospitalizations. Although numerous medications are ...
... , THURSDAY, Aug. 25 (HealthDay News) -- Rheumatoid ... physical activity goals -- called self-efficacy -- are more ... The investigators also found that patients who achieve their ... and a higher quality of life. Researchers in ...
... report that patients with rheumatoid arthritis (RA) who have ... likely to achieve their physical activity goals. According to ... Research , a journal of the American College of ... with lower self-reported arthritis pain and increased health-related quality ...
... million grant from the John D. and Catherine T. ... Research Network on Law and Neuroscience. The MacArthur ... effects of modern neuroscience on criminal law and trying ... The network will be led by Vanderbilt professor Owen ...
Cached Medicine News:Health News:Elsevier congratulates Dr. Charles Silverstein upon his receipt of 2 awards 2Health News:Only 1 in 7 Ob/Gyns Now Performs Abortions, Survey Finds 2Health News:Only 1 in 7 Ob/Gyns Now Performs Abortions, Survey Finds 3Health News:Long-Term Antibiotic Use May Lessen COPD Flare-Ups 2Health News:Long-Term Antibiotic Use May Lessen COPD Flare-Ups 3Health News:Achieving realistic physical activity goals benefits RA patients 2Health News:Landmark law and neuroscience network expands at Vanderbilt 2Health News:Landmark law and neuroscience network expands at Vanderbilt 3
(Date:8/21/2014)... --  Memorial Hermann Health System and The University ... new partnership to provide a new level of specialized breast ... the greater Houston area. ... provider of professional breast radiology services for five of Memorial ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... The spinal column is one of the most delicate and ... from the brain through the column control many key functions ... here can be life altering, and leave the victim in ... body. Though back injury and disease can have an intensely ... available to make things better than ever before. Laser ...
(Date:8/21/2014)...  Decision Resources Group finds that, for the ... and Mexico ... long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist (LAMA)- ... severe cost/coverage constraints. Therefore, new brands of LABA/LAMA ... in these countries—which will considerably expand the chronic ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3
... Calif., Nov. 10, 2010 ChemoCentryx, Inc., today ... the Annual American College of Rheumatology Meeting (ACR). ... is designed to target the receptor for the ... so-called anaphylatoxin that drives inflammatory responses associated with ...
... BLOOMINGTON, Minn., Nov. 10, 2010 A new ... Improvement (ICSI, www.icsi.org ), a nonprofit, health ... care community more than $28 million annually, as ... productivity. The initiative is the first ...
Cached Medicine Technology:ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR) 2ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR) 3ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR) 4Statewide Initiative Launched to Help Ensure Patients Receive Appropriate High-Tech Diagnostic Imaging Exams 2Statewide Initiative Launched to Help Ensure Patients Receive Appropriate High-Tech Diagnostic Imaging Exams 3Statewide Initiative Launched to Help Ensure Patients Receive Appropriate High-Tech Diagnostic Imaging Exams 4Statewide Initiative Launched to Help Ensure Patients Receive Appropriate High-Tech Diagnostic Imaging Exams 5
... Keeler Galilean loupes are ideal ... when increased magnification and a large ... loupes are laser aligned, lightweight and ... ,Fixed working distance and superior depth ...
U tip irrigation-aspiration cannual designed for manual removal of 12 oclock cortex. 23 gauge thin wall irrigation and aspiration lines for maximum aspiration capabilities. Polished finish. Overall l...
... stools come with five legs for ... 18" to 25" (total vertical travel ... rubber castors. Comfortable, durable and fire ... as standard, other colors available by ...
Anterior Stromal Puncture Cannula, 25 g. For treatment of recurrent corneal erosion. Overall length 24 mm. 5/box....
Medicine Products: